RenovoRx (RNXT) Inventory (2025 - 2026)
RenovoRx's (RNXT) quarterly Inventory came in at $383000.0 in Q2 2026, up 1.06% quarter-over-quarter from $379000.0 in Q1 2026.
Analysis
RenovoRx (RNXT) Inventory (2025 - 2026) Analysis & Trends
RenovoRx has disclosed Inventory across 2 years of filings, most recently posting $383000.0 for Q2 2026.
- In Q2 2026, Inventory changed N/A year-over-year to $383000.0; the TTM figure through Jun 2026 stood at $383000.0 (changed N/A YoY), while the FY2025 annual figure was $189000.0, changed N/A from the prior year.
- Inventory came in at $383000.0 for Q2 2026 at RenovoRx, up from $379000.0 in the prior quarter.
- In the past five years, Inventory ranged from a high of $383000.0 in Q2 2026 to a low of $189000.0 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 7.32 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 2.03 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 6.22 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 5.52 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 3.24 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 1.13 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 2.51 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 726.40 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 712.10 Mn |
| 10 | RenovoRx | 83.48 Mn | 83.48 Mn | 766,000.00 | 383,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 383,000.00 |
| Mar 31, 2026 | 379,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 272,000.00 |